SAN DIEGO, Aug. 15, 2017 /PRNewswire/ -- NuVasive, Inc.
(Nasdaq: NUVA), a leading medical device company focused on
transforming spine surgery with minimally disruptive,
procedurally-integrated solutions, announced today the appointment
of Rajesh (Raj) J. Asarpota as the
Company's new executive vice president and chief financial officer
(CFO), effective September 1,
2017.
As a member of NuVasive's global executive team, Mr. Asarpota
will be responsible for the Company's global finance functions
including accounting, FP&A, treasury and tax. He joins NuVasive
with nearly 25 years of experience in financial and executive
leadership roles across the healthcare industry.
Mr. Asarpota began his career at General Electric (GE) in the GE
Financial Management program, including finance roles in commercial
operations, plant and manufacturing analysis, sourcing and R&D
analysis. He then joined the GE Corporate Audit Staff program and
from there moved to GE Healthcare where he held a variety of key
finance operating roles. In the last 15 years, he has accumulated
critical experience in both public and private enterprises,
highlighted by his decade-long tenure at Life Technologies where he
helped drive the growth from a small biotech company to a
$4 billion life sciences leader. More
recently, Mr. Asarpota was the CFO of publicly-traded Questcor
Pharmaceuticals and supported the sale of that company, and then
worked in private equity-backed healthcare companies for the last
several years in executive financial and operational roles.
"Raj brings a strong financial and operational background to the
NuVasive leadership team as we continue to focus on driving revenue
growth and expanding profitability," said Gregory T. Lucier, NuVasive's chairman and chief
executive officer. "I have worked closely with Raj at multiple
companies where we were successful at expanding market share and
transforming operations. He's a proven leader who will drive
significant shareholder value."
Mr. Asarpota earned a bachelor's degree from the University of Bombay in Bombay, India and an MBA from Marquette University in Milwaukee, Wisconsin.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is transforming spine surgery and
beyond with minimally invasive, procedurally-integrated solutions
designed to deliver reproducible and clinically-proven surgical
outcomes. The Company's portfolio includes access instruments,
implantable hardware, biologics, software systems for surgical
planning, navigation and imaging solutions, magnetically adjustable
implant systems for spine and orthopedics, and intraoperative
monitoring service offerings. With $962
million in revenues (2016), NuVasive has an approximate
2,300 person workforce in more than 40 countries serving surgeons,
hospitals and patients. For more information, please visit
www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news
release that are not a description of historical facts are
forward-looking statements that involve risks, uncertainties,
assumptions and other factors which, if they do not materialize or
prove correct, could cause NuVasive's results to differ materially
from historical results or those expressed or implied by such
forward-looking statements. The potential risks and
uncertainties which contribute to the uncertain nature of these
statements include, among others, risks associated with acceptance
of the Company's surgical products and procedures by spine
surgeons, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products (including the iGA®
platform), the Company's ability to effectually manage inventory as
it continues to release new products, its ability to recruit and
retain management and key personnel, and the other risks and
uncertainties described in NuVasive's news releases and periodic
filings with the Securities and Exchange Commission. NuVasive's
public filings with the Securities and Exchange Commission are
available at www.sec.gov. The forward-looking statements contained
herein are based on the current expectations and assumptions of
NuVasive and not on historical facts. NuVasive assumes no
obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
View original content with
multimedia:http://www.prnewswire.com/news-releases/nuvasive-appoints-rajesh-j-asarpota-as-chief-financial-officer-300504346.html
SOURCE NuVasive, Inc.